SCHEMBL6096543

SCHEMBL6096543

CC(C)(C)OC(=O)N1CCc2ccc3ccn(CCOc4c(Cl)cc(Cl)c5cccnc45)c3c2CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.42
HDAC6 Q9UBN7 1/20 0.40
HTT P42858 3/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 1/20 0.39
MPI P34949 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 5/20 0.38
POLB P06746 1/20 0.38
LMNA P02545 2/20 0.36
DTYMK P23919 1/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6096453 0.89 HIF1A (0.48) ALDH1A1MEN1KMT2ANPSR1CYP1A2
SCHEMBL6099152 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL6096847 0.83 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ANPSR1HTT
SCHEMBL6098861 0.80 HIF1A (0.43) ALDH1A1MEN1KMT2ANPSR1CYP1A2
SCHEMBL6098655 0.79 MCL1 (0.41) NPC1ESR2SMN1; SMN2HSD17B10
SCHEMBL6099743 0.76 KDM4E (0.51) ALDH1A1MEN1KMT2ANPSR1CYP1A2
SCHEMBL6098270 0.76 ESR2 (0.44) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL6096133 0.76 P2RX3 (0.41) NPSR1MAPTNPC1RAB9AKDM4E
SCHEMBL6099016 0.75 HTR7 (0.40) ESR2
SCHEMBL6096616 0.71 KDM1A (0.36) ESR2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7022694-B2 Indoles and indolines having 5-HT activity PHARMACIA & UPJOHN COMPANY (US) 2006-04-04 US disclosed
EP-1406902-B1 HEXAHYDROAZEPINO[4,5-G]INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN CO LLC (US) 2005-10-19 EP disclosed
EP-1406902-A1 HEXAHYDROAZEPINO(4,5-G)INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2004-04-14 EP disclosed
US-20030060458-A1 Indoles and indolines having 5-HT activity PHARMACIA & UPJOHN COMPANY 2003-03-27 US disclosed
WO-2003006466-A1 HEXAHYDROAZEPINO (4, 5-G) INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2003-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060458-A1 Indoles and indolines having 5-HT activity TPH1, HTR5A, TPH2 ALDH1A1 479/4885MEN1 655/4885KMT2A 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.